Du forlater nå GSKs nettsider

Denne lenken tar deg til en nettside som ikke tilhører GSK. GSK er ikke ansvarlig for, går ikke god for og aksepterer intet ansvar for informasjon eller meninger på nettsteder til tredjeparter

Fortsett

Tilbake

Patient Case: Stage III MMRp/MSS Endometrial Cancer

Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

Patients with Stage IlI and MMRp Endometrial Cancer

Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany

Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA

Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany

Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

Evaluating Endpoints in Oncology

Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany

Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA

Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and Obstetrics
University of Bielefeld/Klinikum Lippe, Germany

Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

RUBY Part 1 - All Comers Data

Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany

Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA

Dr.Benoit You
Medical Oncologist
Lyon Unversity Hospital, France

Highlights of the RUBY Part 1 Trial Design

Prof. Dr. Klaus Pietzner
Concultant
Charite- University Medicine of Berlin, Germany

Dr. John K.Chan
Director, Gynecologic Oncology
California Pacific Medical
center, San Francisco, USA

Prof.DR. Beynhan Ataseven
Director, Department of Gynecology and
Obstetrics
University of Bielefeld/Klinikum Lippe, Germany

Stage III pMMR/MSS endometrial cancer
Dr.Benoit You
Medical Oncologist Lyon Unversity Hospital, France

  

Har du spørsmål om JEMPERLI for dine pasienter? Kontakt oss 

Jemperli trademark is a registered trademark of the GSK group of companies.
© 2025 GSK group of companies or its licensor.